StockNews.com Initiates Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)
Equities research analysts at StockNews.com assumed coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Get Free Report) in a note issued to investors on Friday. The firm set a “sell” rating on the biotechnology company’s stock. Eiger BioPharmaceuticals Price Performance Shares of NASDAQ EIGR opened at $6.74 on Friday. The firm has a market cap […]
More Stories
Bone ShibaSwap (BONE) Price Hits $0.40 on Major Exchanges
Bone ShibaSwap (BONE) traded down 0.1% against the US dollar during the 1-day period ending at 22:00 PM E.T. on...
Blue Trust Inc. Grows Stock Holdings in Chevron Co. (NYSE:CVX)
Blue Trust Inc. boosted its stake in shares of Chevron Co. (NYSE:CVX – Free Report) by 27.3% during the third...
Jet Protocol (JET) Price Reaches $0.0001
Jet Protocol (JET) traded up 0% against the U.S. dollar during the 24-hour period ending at 22:00 PM E.T. on...
LayerZero (ZRO) Trading 5.4% Lower This Week
LayerZero (ZRO) traded down 2.5% against the U.S. dollar during the one day period ending at 22:00 PM Eastern on...
Qubic (QUBIC) Trading Down 6.7% This Week
Qubic (QUBIC) traded down 0.9% against the dollar during the 24 hour period ending at 22:00 PM ET on October...
BinaryX One Day Trading Volume Hits $247,662.39 (BNX)
BinaryX (BNX) traded up 1.2% against the US dollar during the 1 day period ending at 22:00 PM E.T. on...